171 related articles for article (PubMed ID: 32869534)
21. Conservative approach in localised rhabdomyosarcoma of the bladder and prostate: results from International Society of Paediatric Oncology (SIOP) studies: malignant mesenchymal tumour (MMT) 84, 89 and 95.
Jenney M; Oberlin O; Audry G; Stevens MC; Rey A; Merks JH; Kelsey A; Gallego S; Haie-Meder C; Martelli H
Pediatr Blood Cancer; 2014 Feb; 61(2):217-22. PubMed ID: 23997024
[TBL] [Abstract][Full Text] [Related]
22. Prognosis in childhood rhabdomyosarcoma of the extremity.
Ghavimi F; Mandell LR; Heller G; Hajdu SI; Exelby P
Cancer; 1989 Dec; 64(11):2233-7. PubMed ID: 2804912
[TBL] [Abstract][Full Text] [Related]
23. Controversies in the management of paratesticular rhabdomyosarcoma: is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma?
Wiener ES; Anderson JR; Ojimba JI; Lobe TE; Paidas C; Andrassy RJ; Raney RB; Qualman SJ; Donaldson SS; Maurer HM; Link MP; Crist WM; Grier HE
Semin Pediatr Surg; 2001 Aug; 10(3):146-52. PubMed ID: 11481652
[TBL] [Abstract][Full Text] [Related]
24. Rhabdomyosarcoma: the Stanford experience using a TNM staging system.
Pedrick TJ; Donaldson SS; Cox RS
J Clin Oncol; 1986 Mar; 4(3):370-8. PubMed ID: 3950676
[TBL] [Abstract][Full Text] [Related]
25. Results of intensive therapy in children with localized alveolar extremity rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study.
Heyn R; Beltangady M; Hays D; Lawrence W; Newton W; Crist W; Tefft M; Maurer HM
J Clin Oncol; 1989 Feb; 7(2):200-7. PubMed ID: 2915235
[TBL] [Abstract][Full Text] [Related]
26. Regional nodal involvement and patterns of spread along in-transit pathways in children with rhabdomyosarcoma of the extremity: a report from the Children's Oncology Group.
La TH; Wolden SL; Rodeberg DA; Hawkins DS; Brown KL; Anderson JR; Donaldson SS
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1151-7. PubMed ID: 20542386
[TBL] [Abstract][Full Text] [Related]
27. Adolescents and young adults with rhabdomyosarcoma treated in the European paediatric Soft tissue sarcoma Study Group (EpSSG) protocols: a cohort study.
Ferrari A; Chisholm JC; Jenney M; Minard-Colin V; Orbach D; Casanova M; Guillen G; Glosli H; van Rijn RR; Schoot RA; Cameron AL; Rogers T; Alaggio R; Ben-Arush M; Mandeville HC; Devalck C; Defachelles AS; Coppadoro B; Bisogno G; Merks JHM
Lancet Child Adolesc Health; 2022 Aug; 6(8):545-554. PubMed ID: 35690071
[TBL] [Abstract][Full Text] [Related]
28. Rhabdomyosarcoma: the experience of the pediatric unit of Kasr El-Aini Center of Radiation Oncology and Nuclear Medicine (NEMROCK) (from January 1992 to January 2001).
Abd El-Aal HH; Habib EE; Mishrif MM
J Egypt Natl Canc Inst; 2006 Mar; 18(1):51-60. PubMed ID: 17237856
[TBL] [Abstract][Full Text] [Related]
29. [Localised rhabdomyosarcoma of the extremities in children and adolescents: results of the French experience].
Diepold M; Rey A; Oberlin O; Boulay N; Bergeron C; Glorion C; Mary P; Terrier-Lacombe MJ; Helfre S; Habrand JL; Gentet JC; Defachelles AS; Thomas C; Brisse H; Pierron G; Orbach D
Bull Cancer; 2008 Nov; 95(11):1021-8. PubMed ID: 19036673
[TBL] [Abstract][Full Text] [Related]
30. Clinical spectrum of primary ophthalmic rhabdomyosarcoma.
Shields CL; Shields JA; Honavar SG; Demirci H
Ophthalmology; 2001 Dec; 108(12):2284-92. PubMed ID: 11733272
[TBL] [Abstract][Full Text] [Related]
31. Outcome of localized liver-bile duct rhabdomyosarcoma according to local therapy: A report from the European Paediatric Soft-Tissue Sarcoma Study Group (EpSSG)-RMS 2005 study.
Guérin F; Rogers T; Minard-Colin V; Gaze MN; Terwisscha S; Van Noesel M; De Corti F; Guillén Burrieza G; De Salvo GL; Kelsey A; Orbach D; Ferrari A; Bergeron C; Bisogno G; Martelli H
Pediatr Blood Cancer; 2019 Jul; 66(7):e27725. PubMed ID: 30920113
[TBL] [Abstract][Full Text] [Related]
32. Paratesticular sarcoma in childhood and adolescence. A report from the Intergroup Rhabdomyosarcoma Studies I and II, 1973-1983.
Raney RB; Tefft M; Lawrence W; Ragab AH; Soule EH; Beltangady M; Gehan EA
Cancer; 1987 Nov; 60(9):2337-43. PubMed ID: 3440240
[TBL] [Abstract][Full Text] [Related]
33. Outcome for children with group III rhabdomyosarcoma treated with or without radiotherapy.
Viswanathan AN; Grier HE; Litman HJ; Perez-Atayde A; Tarbell NJ; Neuberg D; Shamberger RC; Marcus KJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1208-14. PubMed ID: 15001265
[TBL] [Abstract][Full Text] [Related]
34. Impact of local control and surgical lymph node evaluation in localized paratesticular rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
Routh JC; Dasgupta R; Chi YY; Shnorhavorian M; Tian J; Walterhouse DO; Breneman J; Wolden SL; Arndt CA; Hawkins DS; Rodeberg DA
Int J Cancer; 2020 Dec; 147(11):3168-3176. PubMed ID: 32525556
[TBL] [Abstract][Full Text] [Related]
35. Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Children's Cancer Study Group. Pediatric Oncology Group.
Lawrence W; Anderson JR; Gehan EA; Maurer H
Cancer; 1997 Sep; 80(6):1165-70. PubMed ID: 9305719
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus: a report of Intergroup Rhabdomyosarcoma Studies I through IV, 1972 through 1997.
Blakely ML; Andrassy RJ; Raney RB; Anderson JR; Wiener ES; Rodeberg DA; Paidas CN; Lobe TE; Crist WM;
J Pediatr Surg; 2003 Mar; 38(3):347-53. PubMed ID: 12632347
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of regional lymph node involvement in childhood extremity rhabdomyosarcoma.
Mandell L; Ghavimi F; LaQuaglia M; Exelby P
Med Pediatr Oncol; 1990; 18(6):466-71. PubMed ID: 2233517
[TBL] [Abstract][Full Text] [Related]
38. The impact of surgical excision in chest wall rhabdomyosarcoma: a report from the Children's Oncology Group.
Hayes-Jordan A; Stoner JA; Anderson JR; Rodeberg D; Weiner G; Meyer WH; Hawkins DS; Arndt CA; Paidas C;
J Pediatr Surg; 2008 May; 43(5):831-6. PubMed ID: 18485948
[TBL] [Abstract][Full Text] [Related]
39. Group II rhabdomyosarcoma and rhabdomyosarcomalike tumors: is radiotherapy necessary?
Schuck A; Mattke AC; Schmidt B; Kunz DS; Harms D; Knietig R; Treuner J; Koscielniak E
J Clin Oncol; 2004 Jan; 22(1):143-9. PubMed ID: 14701776
[TBL] [Abstract][Full Text] [Related]
40. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
Meza JL; Anderson J; Pappo AS; Meyer WH;
J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
